Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedNew study record date entries were added (2026-06-16, 2026-06-12, 2026-06) and older entries (2026-04-13, 2026-03-24, 2026-03) were removed, reflecting updates to the study's record log.SummaryDifference0.1%

- Check13 days agoChange DetectedRecruitment status note 'No longer looking for participants' was added to the page, signaling that enrollment is closed. The header formatting for the Interventions section was adjusted, and a new version stamp (Revision: v3.6.0) along with updated navigation/help sections were introduced.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page now shows revision v3.5.5 instead of v3.5.4, indicating a newer version of the document. This update does not modify study details, eligibility criteria, or how the page operates.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new version of the page's documentation. This change does not modify the public content or user-facing features.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study’s listed results/measurement section has been updated, including endpoint time frames and the detailed wording of response and survival measures for cohorts 1–8 and cohort 9. It also reflects newer results posting/submission dates and study-document metadata updates rather than new study design elements like interventions, eligibility, or locations.SummaryDifference3%

- Check99 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.